1. Home
  2. RGEN vs VNO Comparison

RGEN vs VNO Comparison

Compare RGEN & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$123.31

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Logo Vornado Realty Trust

VNO

Vornado Realty Trust

HOLD

Current Price

$32.04

Market Cap

5.7B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
VNO
Founded
1981
1946
Country
United States
United States
Employees
N/A
3145
Industry
Medical/Dental Instruments
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
5.7B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
RGEN
VNO
Price
$123.31
$32.04
Analyst Decision
Buy
Hold
Analyst Count
12
10
Target Price
$167.67
$33.00
AVG Volume (30 Days)
999.5K
1.6M
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
2.52%
EPS Growth
286.96
N/A
EPS
0.15
N/A
Revenue
$141,236,000.00
N/A
Revenue This Year
$14.30
N/A
Revenue Next Year
$14.52
$5.42
P/E Ratio
$840.47
$7.08
Revenue Growth
35.10
N/A
52 Week Low
$109.50
$24.57
52 Week High
$175.77
$43.37

Technical Indicators

Market Signals
Indicator
RGEN
VNO
Relative Strength Index (RSI) 51.76 70.46
Support Level $121.25 $25.19
Resistance Level $130.12 $32.81
Average True Range (ATR) 6.50 0.86
MACD 0.60 0.24
Stochastic Oscillator 43.50 86.78

Price Performance

Historical Comparison
RGEN
VNO

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

About VNO Vornado Realty Trust

Vornado Realty Trust is a fully integrated real estate investment trust with a portfolio of New York City office, retail, and multifamily assets, and the developer of the new Penn District. While concentrated in New York, the trust also owns assets in both Chicago and San Francisco. It generates revenue in the form of property rentals, fees charged for trade shows, parking revenues, management and leasing fees, etc. Vornado operates in the following reportable segments: New York (its key revenue-generating market) and Other.

Share on Social Networks: